Application Information

Application Number : 2024/006179

Application Date : 28-03-2019

Application Type : EPC Fasikül

Grant Number : 2024-GE-350278

Grant Date : 20-05-2024

Registration Number : 2024 006179

Registration Date : 2024-06-21

Protection Type : Patent

European Patent Publication Number (B1) : EP3773715B1

European Patent Application Number : EP19722256.5

Applicants

Person No	Name	Address
6801224	ELI LILLY AND COMPANY	LILLY CORPORATE CENTER, INDIANAPOLIS, INDIANA 46285 A.B.D.

Inventors

Person No	Name	Address
7695833	James Benedict CANAVAN	C/O ELI LILLY AND COMPANY P.O. BOX 6288 INDIANAPOLIS, INDIANA 46206-6288 A.B.D.
7695834	Stuart William FRIEDRICH	C/O ELI LILLY AND COMPANY P.O. BOX 6288 INDIANAPOLIS, INDIANA 46206-6288 A.B.D.
7695837	Jay Lawrence TUTTLE	C/O ELI LILLY AND COMPANY P.O. BOX 6288 INDIANAPOLIS, INDIANA 46206-6288 A.B.D.
7695836	Catherine MILCH	C/O ELI LILLY AND COMPANY P.O. BOX 6288 INDIANAPOLIS, INDIANA 46206-6288 A.B.D.
7695835	Kathryn Ann KRUEGER	C/O ELI LILLY AND COMPANY P.O. BOX 6288 INDIANAPOLIS, INDIANA 46206-6288 A.B.D.

Invention Information

Name Of Invention	Ülseratif kolit tedavisinde mirikizumab.
Summary Of Invention	Mevcut buluş, ülseratif kolit tedavisi usullerinde kullanıma yönelik mirikizumab ile ilgilidir.

Attorney Information

Name	SULTAN PINAR ŞEN STOCK FİKRİ MÜLKİYET HİZMETLERİ ANONİM ŞİRKETİ
Address	BÜYÜKDERE CAD. NO:173 LEVENT - ŞİŞLİ- 34394/ İSTANBUL

Priority Information

Date of Priority	Priority Number	Country of Priority
30-03-2018	US 201862650314P	US

Classes of The Invention

Patent Application Procedures

Date	Date of Notification	Operation
27-02-2026		Yıllık Ücret Ödeme Talebi
28-02-2025		Yıllık Ücret Ödeme Talebi
	22-05-2024	Şekli Kontrol Yapıldı. Başvuru / İstem / Fasikül Onaylandı.
20-05-2024		EPO'dan Gelen Patent Fasikül

Publications

Publication Date	Description
21-06-2024	Avrupa Patent Fasiküllerinin İlanı

Payment Dates

Row	Year	Payment Date	Amount Paid (₺)
7	2025	28-02-2025	6280.0
8	2026	27-02-2026	8530.0